CSIMarket
 


Antriabio, Inc.  (FMYY)
Other Ticker:  
 
 

FMYY's Capital Expenditures Growth by Quarter and Year

Antriabio,'s Capital Expenditures results by quarter and year




FMYY Capital Expenditures (in millions $) FY 0 FY -1 FY -2 FY -3
IV Quarter 0.00 0.00 0.00 0.00
III Quarter 0.00 0.00 0.00 0.00
II Quarter 0.00 0.00 0.00 0.00
I Quarter 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.00 0.00



FMYY Capital Expenditures 0 Y/Y Growth Comment
Antriabio, Inc. in the 0 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the 0, Antriabio, Inc. achieved the best Capital Expenditures growth in Major Pharmaceutical Preparations industry. While Antriabio, Inc.' s Capital Expenditures no change of % ranks overall at the positon no. in the 0.




FMYY Capital Expenditures ( Y/Y Growth %) 0
-1 -2 -3
IV Quarter - - - -
III Quarter - - - -
II Quarter - - - -
I Quarter - - - -
FY   - - - -

Financial Statements
Antriabio,'s 0 Capital Expenditures $ 0.00 millions FMYY's Income Statement
Antriabio,'s -1 Capital Expenditures $ 0.00 millions Quarterly FMYY's Income Statement
New: More FMYY's historic Capital Expenditures Growth >>


FMYY Capital Expenditures (Quarter on Quarter Growth %)

0
-1 -2 -3
IV Quarter - - - -
III Quarter - - - -
II Quarter - - - -
I Quarter - - - -
FY (Year on Year)   - - - -




Capital Expenditures 0 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures 0 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years -3, -2, -1, 0

Antriabio,'s Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FMYY's Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FMYY's Q/Q Capital Expenditures Comment


Antriabio,'s 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2014)
12 Months Ending
(Sep 30 2013)
12 Months Ending
(Jun 30 2013)
12 Months Ending
(Dec 31 2012)
12 Months Ending
(Sep 30 2012)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Mar 31 2014 period, Antriabio,'s cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Antriabio, Inc. achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Mar 31 2014 period, Antriabio,'s cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Antriabio, Inc. achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
FMYY's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for FMYY's Competitors
Capital Expenditures Growth for Antriabio,'s Suppliers
Capital Expenditures Growth for FMYY's Customers

You may also want to know
FMYY's Annual Growth Rates FMYY's Profitability Ratios FMYY's Asset Turnover Ratio FMYY's Dividend Growth
FMYY's Roe FMYY's Valuation Ratios FMYY's Financial Strength Ratios FMYY's Dividend Payout Ratio
FMYY's Roa FMYY's Inventory Turnover Ratio FMYY's Growth Rates FMYY's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending
Becton Dickinson And Company-1.67%$ -1.666 millions
Celgene Corp-2.76%$ -2.756 millions
Abaxis Inc-5.28%$ -5.283 millions
Abbott Laboratories-7.09%$ -7.092 millions
Ocata Therapeutics, Inc.-7.10%$ -7.099 millions
3m Company-9.57%$ -9.568 millions
Dyne Therapeutics Inc -15.00%$ -15.000 millions
St Jude Medical Inc-29.23%$ -29.231 millions
Waters Corp-30.17%$ -30.166 millions
American Caresource Holdings, Inc.-31.90%$ -31.902 millions
Ipc Healthcare, Inc.-32.61%$ -32.615 millions
Edwards Lifesciences Corporation-37.83%$ -37.826 millions
Orthofix Medical Inc -38.47%$ -38.465 millions
Merck and Co Inc -41.60%$ -41.595 millions
Perkinelmer Inc-49.11%$ -49.108 millions
Intelgenx Technologies Corp -60.51%$ -60.512 millions
Cv Sciences Inc -63.40%$ -63.398 millions
Erba Diagnostics, Inc.-69.38%$ -69.379 millions
Iovance Biotherapeutics Inc -72.95%$ -72.946 millions
Fonar Corporation-80.12%$ -80.118 millions
Dendreon Corp-92.27%$ -92.268 millions
Siga Technologies Inc-95.10%$ -95.100 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com